PharmaShots | Incisive News in 3 Shots

Subscribe Now

Peripheral Artery Disease

Johnson & Johnson MedTech Launches Shockwave Javelin Peripheral IVL Catheter in the US

Johnson & Johnson MedTech Launches Shockwave Javelin Peripheral IVL Catheter in the US

March 6, 2025

Johnson & Johnson Reports the Acquisition of Shockwave Medical to Strengthen its MedTech Cardiovascular Portfolio

Johnson & Johnson Reports the Acquisition of Shockwave Medical to Strengthen its MedTech Cardiovascular Portfolio

April 5, 2024

Avery Ince, VP, Medical Affairs - CVM Franchise, Janssen Shares his Views on New Data from P-III VOYAGER PAD Trial

Avery Ince, VP, Medical Affairs - CVM Franchise, Janssen Shares his Views on New Data from P-III VOYAGER PAD Trial

June 6, 2023

AstraZeneca Entered into an Exclusive License Agreement with Regio Biosciences to Initiate P-IIa Trial of REG-101 for Peripheral Artery Disease

AstraZeneca Entered into an Exclusive License Agreement with Regio Biosciences to Initiate P-IIa Trial of REG-101 for Peripheral A...

February 4, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us